Fibronostics’ Post

Liver disease can progress silently, but the good news is that early stages are reversible with timely intervention! The progression of Liver disease: 🔹 Healthy Liver: Less than 5% fatty cells.
 🔹 Fatty Liver/Inflammation: The liver is enlarged due to fat deposits or inflammation. At this stage, damage is reversible. 🔹 Fibrosis: Scar tissue begins to form, but the liver can still heal with intervention—reversible if caught early. 🔹 Cirrhosis: The liver hardens, leading to loss of function. This stage is often irreversible and can lead to severe health consequences. The first three stages are reversible if detected early. This is why early detection is critical. At Fibronostics, we’re committed to enabling healthcare professionals to identify liver disease before it’s too late with our non-invasive solutions. By providing comprehensive insights into liver health, patients and clinicians can be empowered to take timely action and potentially reverse liver damage. Don’t wait until it's too late. Early detection can save lives. #LiverHealth #LiverDisease #EarlyDetection #LIVERFASt #LIVERSTAT #HealthcareInnovation

It’s been an amazing couple of days, and we’re so grateful for the meaningful conversations and connections we’ve made. If you haven’t yet, there’s still time to stop by our booth and connect with us at Booth 808 at the Donald E. Stephens Convention Center to discover how LIVERFASt can revolutionize liver health management in your practice. Don’t miss out on your last chance to meet our CEO, Brock Smith, and our Liver Health Specialist, Ryan Schneider, ask questions, and explore the future of liver diagnostics with us. Let’s make the most of this final day! #PriMedMIdwest #CMEConference #LIVERFASt #Fibroconference #MeetOurTeam 

Only 1 day to go until Pri-Med Midwest 2024 kicks off! Our Fibronostics team is all set and excited to meet you at the Donald E. Stephens Convention Center from October 8−10. Don’t miss the chance to learn about LIVERFASt, our innovative liver health assessment solution that’s helping primary care providers make smarter, faster clinical decisions. Swing by our booth to meet the our team, Brock Smith and Ryan Schneider, and see how LIVERFASt can elevate liver care in your practice. We can't wait to connect! See you tomorrow! #PriMedMIdwest #CMEConference #LIVERFASt #Fibroconference #MeetOurTeam 

October is Liver Awareness Month! Liver health is something we often take for granted, but it plays a crucial role in our overall well-being. From processing nutrients to detoxifying the body, the liver is a powerhouse that keeps us functioning. Yet, liver diseases often go unnoticed until they become severe. This October, let’s take the opportunity to raise awareness, support those affected by liver conditions, and emphasize the importance of early detection and prevention. At Fibronostics, we are proud to contribute to liver health through our innovations, which helps in early detection and management of liver diseases. By leveraging technology, we aim to make liver health assessments more accessible and effective for both patients and healthcare providers. Here are a few steps we can all take to protect our liver health: ✅ Maintain a balanced diet ✅ Exercise regularly ✅ Limit alcohol consumption ✅ Get vaccinated against hepatitis ✅ Regularly monitor your liver function Let’s work together to make liver health a priority and ensure a healthier future for all. 💚 #LiverAwarenessMonth #LiverHealth #PreventLiverDisease #HealthcareInnovation #LIVERFASt

The Fibronostics team will be at the Pri-Med Midwest - Primary Care CME/CE Conference & Expo next week, from October 8−10, 2024, at the Donald E. Stephens Convention Center! We’re thrilled to showcase LIVERFASt, our cutting-edge non-invasive solution for assessing liver health. If you're attending, be sure to swing by our booth to learn how LIVERFASt is transforming the way we manage liver diseases. Come say hi, and let’s discuss how we can support your practice in delivering the best patient care. See you Chicago! #PriMedMIdwest #CMEConference #LIVERFASt #Fibroconference #MeetOurTeam

Did you know that your daily coffee habit could be doing more than just perking you up? According to research, drinking two cups of coffee a day can reduce the risk of cirrhosis by 44%, while four cups can lower it by an impressive 65%! As we celebrate this beloved beverage today, let’s raise a mug to coffee’s remarkable benefits and the power of prevention in maintaining liver health. Whether it’s your morning espresso or an afternoon latte, here’s to a cup of wellness! Happy International Coffee Day! #InternationalCoffeeDay #LiverHealth #CoffeeLovers #Wellness #FibroHealthTips

Our recent study demonstrated that the combination of LIVERSTAT and Fibroscan offers a powerful one-step assessment for MASLD-related fibrosis. This combination: ✅ Identifies twice as many advanced fibrosis (F3F4) cases compared to the traditional FIB-4 and Fibroscan combo. ✅ Eliminates the "grey zone" in detection, ensuring no F3F4 patients are missed.
 ✅ Detects 41% of F3F4 cases missed by FIB-4. This streamlined approach offers a more accurate and efficient tool for early fibrosis identification, helping to ensure timely intervention and improved patient outcomes. Find out more about the study: https://zurl.co/9MQQ #MASLD #LIVERSTAT #Fibroscan #AdvancedFibrosis #LiverHealth #MASH

As Fibronostics continues to innovate in non-invasive diagnostics, expanding into Malaysia, an emerging market with immense potential, was a strategic move. To succeed in this new landscape, we needed a partner who understood the intricacies of local regulations and could ensure a smooth registration process with the Medical Device Authority (MDA). Andaman Medical stood out with their deep expertise and hands-on support in navigating these complexities. Find out how Andaman Medical helped us streamline our journey into this promising market. Read more in their latest post!

LIVERFASt™ played a pivotal role as the screening tool in the American Liver Foundation's pilot MASLD Screening Program. By leveraging LIVERFASt™ in federally-qualified health centers and community clinics, we provided a crucial "first screen" for MASLD in high-risk populations. This non-invasive tool enabled early detection, followed by education and connection to care for those in need. With MASLD/MASH becoming a major healthcare crisis in the U.S., the pilot demonstrated the feasibility of using LIVERFASt™ for widespread screening in primary care settings. As ALF aims to expand its Think Liver Think Life campaign nationwide over the next 5 years, LIVERFASt™ will be instrumental in advancing early diagnosis, education, and access to care for liver disease. Learn more about the Screening Program at: https://zurl.co/CEz2 & https://zurl.co/Gu9G 
#LiverHealth #MASLD #MASH #Screening #LIVERFASt #ThinkLiverThinkLife #PublicHealth #EarlyDetection

Our liver works hard to keep us healthy, so let’s return the favor! Here are a few simple habits to prevent liver disease and keep this vital organ functioning at its best: Eat a balanced diet - Incorporate fiber-rich fruits, veggies, and whole grains while reducing processed foods and unhealthy fats. Stay hydrated - Drinking enough water supports liver detoxification and keeps everything running smoothly. Stay active – Regular exercise helps maintain a healthy weight, reducing the risk of fatty liver disease. Limit alcohol and avoid toxins – Overconsumption of alcohol and exposure to harmful chemicals can damage the liver over time. Get regular checkups – Early detection is key, so don’t skip your routine health screenings! Your liver plays a critical role in your overall health – let’s keep it strong and healthy! 
#LiverHealth #PreventLiverDisease #HealthyLiving #WellnessMatters